Adial Pharmaceuticals, Inc. (ADIL) vs IRIDEX Corporation (IRIX)

A side-by-side comparison of Adial Pharmaceuticals, Inc. and IRIDEX Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ADIL vs IRIX

growth of $100 · dividends reinvested · last 8y
ADIL -99.8% (-54.9%/yr)IRIX -91.3% (-26.3%/yr)IRIX compounded faster over this window
Log scale — wide-divergence pair
001101001kStart $1002020202220242026$0$9
ADIL IRIX

ADIL vs IRIX: by the numbers

  • •IRIX is the larger company ($12M vs $11M market cap).
  • •Both run net losses; ADIL's is the smaller (0.00% vs -6.88% net margin).

Metrics side by side

Valuation

MetricADILIRIX
P/S ratioN/A0.24

Profitability

MetricADILIRIX
Gross margin0.00%36.23%
Operating margin0.00%-5.39%
Net margin0.00%-6.88%
ROE-37052.06%-97.47%
ROIC-240.64%-19.53%

Growth (annualized)

MetricADILIRIX
Revenue CAGR (5Y)N/A-0.57%
Total return CAGR (5Y)-71.86%-38.13%

Frequently asked

How have ADIL and IRIX total returns compared?
Over the past 5 years, ADIL delivered -71.86% and IRIX delivered -38.13% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.